PDF

Financial Results for the nine months ended 30 September 2018

Financial Results for the nine months ended 30 September 2018. Net profit attributable to Aamal equity holders QAR 336.3m

PDF

Disclosure of Third-Quarter Financial Statements

Aamal's Participation in Corporate Governance Conference

As a result of its commitment to the highest standards of corporate governance

Statement Regarding Souq Al-Haraj

A clarification to the public to deny any news that state otherwise.

Financial Results for the six months ended 30 June 2018

Net profit attributable to equity holders: QAR 228.9 million

PDF

Disclosure of Half-Year Financial Statements

Financial Results for the 1st quarter ended 31 March 2018

Net profit attributable to equity holders: QAR 115.8m

PDF

Aamal Company Q.P.S.C. (“Aamal”) Results of the Annual Ordinary and Extra Ordinary General Assembly Meeting

AGM approves to distribute 6% dividends of the nominal value of each share (QR 0.6 for each share)
AGM approved voting of three candidates nominated for the Independent Directorship seats on the Board
AGM Approved amendments to the Company’s Article of Association

PDF

Board of Directors of Aamal Company Q.P.S.C to hold a meeting on Monday, 30 April 2018, to discuss first quarter financial results for the period ending 31 March 2018

The Board of Directors of Aamal Company Q.P.S.C. will hold a meeting on April 30th 2018 to discuss the financial results of the first quarter for the period ending March 31st 2018.

Aamal Medical signs agreement with leading Turkish healthcare firm

Aamal Medical has signed an agreement with Simeks Medical (“Simeks”), the Turkish healthcare company, to supply medical equipment with advanced medical technologies.

PDF